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Background: Some differences have been reported in the biotransformation of ginsenosides, probably
due to the types of materials used such as ginseng, enzymes, and microorganisms. Moreover, most
microorganisms used for transforming ginsenosides do not meet food-grade standards. We investigated
the statistical conversion rate of major ginsenosides in ginsenosides model culture during fermentation
by lactic acid bacteria (LAB) to estimate possible pathways.
Methods: Ginsenosides standard mix was used as a model culture to facilitate clear identiﬁcation of the
metabolic changes. Changes in eight ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, and Rg2) during
fermentation with six strains of LAB were investigated.
Results: In most cases, the residual ginsenoside level decreased by 5.9e36.8% compared with the initial
ginsenoside level. Ginsenosides Rb1, Rb2, Rc, and Re continuously decreased during fermentation. By
contrast, Rd was maintained or slightly increased after 1 d of fermentation. Rg1 and Rg2 reached their
lowest values after 1e2 d of fermentation, and then began to increase gradually. The conversion of Rd,
Rg1, and Rg2 into smaller deglycosylated forms was more rapid than that of Rd from Rb1, Rb2, and Rc, as
well as that of Rg1 and Rg2 from Re during the ﬁrst 2 d of fermentation with LAB.
Conclusion: Ginsenosides Rb1, Rb2, Rc, and Re continuously decreased, whereas ginsenosides Rd, Rg1,
and Rg2 increased after 1e2 d of fermentation. This study may provide new insights into the metabolism
of ginsenosides and can clarify the metabolic changes in ginsenosides biotransformed by LAB.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ginseng (Panax ginseng Meyer) is a traditional herbal medicine
that has been used for a long time in Asia because of its numerous
medicinal functions [1] and its use continues to increase world-
wide. Ginseng contains various bioactive components, including
ginsenosides (ginseng saponins), acidic polysaccharides, poly-
phenols, and polyacetylenes [2]. Among these components, ginse-
nosides, which are glycosides with steroids or triterpenes as
aglycons, have been highly characterized for their biological activ-
ities. To date, more than 50 ginsenosides have been identiﬁed and
are divided into two major categories based on their chemical
structures: (1) protopanaxadiol [PPD, aglycone (20S)-proto-
panaxadiol], which includes ginsenosides Rb1, Rb2, Rc, Rd, Rg3,e, Dongshin University, 185 Geonj
.
ht  2016, The Korean Society of G
d/4.0/).compound K (CK), and Rh2, and (2) protopanaxatriol [PPT, aglycone
(20S)-protopanaxatriol], which includes ginsenosides Re, Rf, Rg1,
Rg2, and Rh1 [3]. Among those, six major ginsenosides (Rb1, Rb2,
Rc, Rd, Re, and Rg1) have been determined to account for 90% of the
total ginsenoside content of P. ginseng Meyer [4].
The sugar chains of ginsenosides were found to be closely
related to their functionality. The conversion of ginsenosides into
smaller deglycosylated forms may therefore markedly change the
biological activity especially effective for in vivo physiological ac-
tions [5]. For example, CK transformed from ginsenosides Rb1, Rb2,
and Rc was reported to demonstrate improved anti-inﬂammatory
and antitumor effects [6,7]. Therefore, the transformation of these
major ginsenosides (Rb1, Rb2, Rc, Rd, Re, and Rg1) into smaller
deglycosylated ginsenosides is necessary. Many studies haveae-ro, Naju, Jeonnam, 58245 Korea.
inseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
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deglycosylated forms using physicochemical transformation
methods such as heating and acid treatment [8,9]. By contrast,
biological approaches such as microbial or enzymatic methods
have been proposed, owing to their marked selectivity, mild reac-
tion conditions, environmental compatibility, and convenience for
industrial applications [10,11]. Many studies have identiﬁed the
biotransformation of ginsenosides into smaller deglycosylated
forms such as Rb1/ Rd, F2, Rg3, CK [12], Re, Rb1, Rc/ Rg1, Rd, CK
[13], Rb1 / Rd [1], and Rb1 / Rd, Rg3 [10]. The structures and
possible biotransformation pathways of PPD- and PPT-type ginse-
nosides by microbial or enzymatic methods are shown in Fig. 1. The
speciﬁc pathways of the PPD and PPT ginsenosides were indicated
based on published information (see Table S1 in Supplementary
Material online). Some differences in the biotransformation of
ginsenosides have been reported according to the biological
methods used; however, these differences may also be due to the
types of materials used such as ginseng, enzymes, and microor-
ganisms. Moreover, most microorganisms used for biological
transformation do not satisfy food-grade standards [14].
Characterization of the biotransformation of ginsenosides dur-
ing fermentation is needed to explain the pharmacological actions
of fermented ginseng. However, most reports only deal with one or
a few ginsenosides, ignoring the full action of ginsenosides.
Moreover, the ginsenosides levels in ginseng plants are inﬂuenced
by a range of factors such as the species, age, part of the plant,
cultivation method, harvesting season, and preservation method
[15]. It can be difﬁcult to clearly identify the comprehensive gin-
senoside transformation, probably due to the chemical complexity
of the metabolites, the lack of reference standards, experimental
error during the extraction of ginsenosides, or the limitations
inherent in analytical methods [16]. Therefore, the investigation of
targeted changes in major ginsenosides during fermentation with
selected microorganisms is needed [17].
In this paper, the biotransformation in ginsenosides using food-
compatible microorganisms [lactic acid bacteria (LAB)] was iden-
tiﬁed and quantiﬁed. A standard mix of ginsenosides containing
eight major ginsenosides was used as a model culture to facilitate
clear identiﬁcation of the metabolic changes.
2. Materials and methods
2.1. Materials
Ginseng ginsenosidesmix, including Rb1, Rb2, Rc, Rd, Re, Rf, Rg1,
and Rg2 (100 mg/mL of each component in methanol), was pur-
chased from Sigma-Aldrich (St. Louis, MO, USA). Methanol (1 mL)
was evaporated under vacuum using liquid nitrogen, and diluted
with 100 mL of distilled water for use as a ginsenosides model
culture (GMC) for LAB.
2.2. Fermentation
Six LAB strains were selected for this study based on b-gluco-
sidase activity as previously reported [18,19]. Lactobacillus planta-
rum KCCM11322, Lactobacillus delbrueckii subsp. bulgaricus
KCCM35463, Lactobacillus fermentum KCCM40401, and Biﬁdo-
bacterium longum KCCM11953 were purchased from the Korean
Culture Center of Microorganisms (KCCM, Seoul, Korea).
L. delbrueckii subsp. lactis KCTC 1058 and Leuconostoc mesenteroides
subsp. mesenteroides KCTC 3718 were purchased from the Korean
Collection for Type Cultures (KCTC, Daejeon, Korea). The strain was
inoculated into ManeRogosaeSharpe (MRS, Difco, Sparks, MD,
USA) broth and grown at 37C for 48 h to obtain a ﬁnal cell count of
108 CFU/mL. GMC was produced using ginseng ginsenosides mixdiluted with distilled water by supplementing MRS broth (5.5%)
with the LAB nutrient. GMCwas inoculated with 1% (vol/vol) of LAB
starter culture and fermentation was performed at 30C for 5 d.
Samples were taken on the 1st, 2nd, 3rd, and 5th days of fermentation
for chemical and microbiological analyses.
2.3. Microbiological analysis
One milliliter of GMC was aseptically transferred into a conical
tube prior to the preparation of 1/10 serial dilutions for microbio-
logical analysis. LAB count was determined after growing the LAB in
MRS agar and incubating at 37C for 48 h. Tests were carried out in
duplicate and the results were expressed as log CFU/g.
2.4. Physicochemical analysis
After centrifuging for 5 min at 12,000 rpm, the supernatant
liquid was ﬁltered through a 0.45-mmmembrane (Whatman No. 2)
and used in all of the test systems. The total soluble solids (degrees
Brix) in GMC were measured using a digital refractometer (PR-32,
Atago, Tokyo, Japan) with temperature compensation. pH was
determined using a pH meter (pH-250L, ISTEK, Seoul, Korea) and
the means of three measurements were recorded. Titratable acidity
(TA) as lactic acid was determined by titrating to pH 8.3 with 0.1N
NaOH. Reducing sugars were measured according to the 3,5-
dinitrosalicylic acid (DNS) method [20]. Reaction mixtures con-
tained 3 mL of the sample and 3 mL of the DNS reagent. Glucose
solutionwas used for the standard curve. The reaction mixture was
heated in a water bath for 5 min to develop a red-brown color and
was then cooled to room temperature in a water-ice bath. Subse-
quently, 1 mL of a 40% potassium sodium tartrate solution was
added to stabilize the color. The absorbance was measured at
540 nm using a spectrophotometer (UV-1601; Shimadzu, Kyoto,
Japan).
2.5. b-glucosidase activity
Beta-glucosidase activity was evaluated via the colorimetric
method using p-nitrophenyl-b-D-glucopyranoside (pNPG) as a
substrate [10]. The reaction mixture, which contained 5mM of
pNPG in 1 mL of sodium phosphate buffer (pH 7.0) and 100 mL of
enzyme solution, was incubated at 30C for 10 min. The reaction
was subsequently terminated by adding 1 mL of 0.5M NaOH, and
the absorption of the released p-nitrophenol (PNP) was measured
against the prepared reagent blank at 400 nm using a spectro-
photometer. One unit of b-glucosidase activity was deﬁned as the
quantity of enzyme required to liberate 1 mM of pNP/min under
standard conditions.
2.6. Ginsenosides analysis
Eight ginsenoside peaks were detected by liquid chromatog-
raphy (Agilent 1200 Series) coupled with 6410A triple quadrupole
mass spectroscopy (Agilent, Santa Clara, California, USA). Samples
were ionized and detected by electrospray ionizationemass spec-
trometry with the selected ion-monitoring mode of negative ions.
The nebulizer gas was set to 10 L/min at a temperature of 320C and
the capillary voltages were set to 4 kV. Separation was achieved
using the XDB-C18 column (50 mm  4.6 mm i.d., 1.8 mm; Agilent)
with a column oven temperature of 35C. The mobile phase was
composed of (A) 5mM ammonium acetateeformic acid (0.1%, vol/
vol) and (B) methanol. The mobile phase B was kept at 50% for
2 min and then gradually increased to 90% for 25 min. The ﬂow rate
was kept at 0.35 mL/min, and 5 mL of the sample solution was
injected in each run.
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Fig. 1. The structures and possible biotransformation pathways of (A) protopanaxadiol (PPD)- and (B) protopanaxatriol (PPT)-type ginsenosides by microbial or enzymatic methods.
The pathways of ginsenosides were drawn based on published information and the reference numbers are indicated in Table S1 (see Supplementary Material online). The
fundamental chemical structures of ginsenosides were simply expressed to highlight their conversion into smaller deglycosylated forms.
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Fig. 3. pH and titratable acidity (TA) of ginsenosides model cultures fermented with
six lactic acid bacteria strains. TA was expressed as percent lactic acid. Values are
expressed as the mean  SD (n ¼ 3).
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Statistical analyses were performed using the SPSS version 14.0
statistical package for windows (SPSS Inc., Chicago, IL, USA). Anal-
ysis of variance and Duncan multiple range tests were applied to
the data to determine signiﬁcant differences, and a value of p< 0.05
was considered statistically signiﬁcant.
3. Results and discussion
3.1. Microbiological analysis
The structures and possible biotransformation pathways of PPD-
and PPT-type ginsenosides by microbial or enzymatic methods are
shown in Fig. 1. The speciﬁc pathways of the PPD and PPT ginse-
nosides were indicated based on published information (see
Table S1 in Supplementary Material online). Some differences have
been reported in the biotransformation of ginsenosides according
to the types of materials used such as ginseng, enzymes, and mi-
croorganisms. We investigated the statistical conversion rate of
major ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, and Rg2) in GMC
during fermentation by LAB to estimate the possible pathways
involved.
Fig. 2 shows the growth kinetics of LAB during fermentation in
GMCs inoculated with six strains of LAB. Each batch was inoculated
with 1% LAB by volume, with a ﬁnal cell count of 8e9 log CFU/mL.
GMCs contained about 9e11 log CFU/mL on the 1st day of
fermentation, which increased slightly on the 2nd day of fermen-
tation, with the exception of one starter culture (L. fermentum).
Afterward, the number of viable cells in GMCs began to decrease
and the cell population reached 6e7.5 log CFU/mL in all tested
samples after 5 d of fermentation. Although similar, the population
growth pattern displayed by LAB in GMCs showed several varia-
tions in the inoculated strains.
3.2. Physicochemical analysis
The reducing sugar contents before fermentation of the GMCs
was 550 mg/L. The reducing sugars were depleted to 20e25 mg/L
by all strains except for L. delbrueckii subsp. bulgaricus (68 mg/L,
data not shown). These results conﬁrmed that fermentable sugar
was almost exhausted within the 5 d of fermentation. The pH and
the TA of GMCs fermented with the six LAB strains are presented in
Fig. 3. The pH of GMCs before inoculation was 6.37 and the value
decreased during fermentation. Although the viable LAB numbersLactobacillus fermentum
L. delbrueckii subsp. lactis
Bifidobacterium longum
Leuconostoc mesenteroides 
subsp. mesenteroides
Lactobacillus plantarum
Lactobacillus delbrueckii 
subsp. bulgaricus
Fig. 2. Growth kinetics of lactic acid bacteria (LAB) during fermentation in ginseno-
sides model cultures inoculated with six LAB strains. Each batch was inoculated with
1% LAB by volume, with a ﬁnal cell count of 8e9 log CFU/mL. Values are expressed as
the mean  standard deviation (n ¼ 3).in the GMCs inoculated with L. fermentum and B. longum were
relatively higher than those in other samples during fermentation,
the pH values were signiﬁcantly higher at 4.2e4.3 compared with
the other GMCs (3.8e3.9). In general, the TA was inversely pro-
portional to the pH value. As expected, the GMCs inoculated with
L. fermentum and B. longum had lower TA values, with ﬁnal values of
0.92e1.02%. GMCs inoculated with other strains had signiﬁcantly
higher TA value of 1.37e1.53%. It may be that the pH reduction was
due to LAB rapidly becoming the predominant microorganism,
producing lactic acid and leading to pH reduction.
3.3. b-glucosidase activity
The b-glucosidase activity of GMCs fermented with six LAB
strains are listed in Fig. 4. As the fermentation progressed, b-
glucosidase activity of all GMCs increased and peaked at 2 d of
fermentation. Afterward, the b-glucosidase activity in the samples
began to decrease and reached 74e109 U in all tested samples on
the 5th day of fermentation. Although b-glucosidase activity was
lower compared with the 2nd day of fermentation, its activity in the
GMCs inoculated with L. mesenteroides and L. plantarum stabilized
or decreased slowly by the 5th day of fermentation. This indicated
that a fermentation period longer than 5 d was needed for the
biotransformation of ginsenosides. By contrast, a large and rapid
decrease in b-glucosidase activity was observed in the GMCs
inoculated with L. fermentum and B. longum. The b-glucosidase
activity pattern displayed by L. delbrueckii subsp. bulgaricus in GMC
was signiﬁcantly lower than other tested samples during fermen-
tation. Because of the special structure of the dammarane skeleton,Lactobacillus  fermentum
Bifidobacterium longum
Lactobacillus plantarum
L. delbrueckii subsp. lactis
Leuconostoc 
mesenteroides subsp. mesenteroides
Lactobacillus 
delbrueckii subsp. bulgaricus
Fig. 4. b-Glucosidase activity of ginsenosides model cultures fermented with six lactic
acid bacteria strains. Values are expressed as the mean  SD (n ¼ 3).
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linkages [14]. To date, several b-glucosidases producing LABs have
been reported [21e23]. Yan et al [24] puriﬁed seven b-glucosidase
fractions from Paecilomyces Bainier sp. 229, and found that the
biotransformation pathway of Rb1 to CK by each fraction was
different. Speciﬁc bioconversion of ginsenoside Rb1 into various
ginsenosides may be possible using the appropriate combination of
speciﬁc microbial enzymes.
3.4. Biotransformation of ginsenosides
The residual ginsenoside levels on the 5th day of fermentation are
shown in Table 1. In most cases, the residual ginsenoside level
decreased by 5.9e36.8% compared with the initial value. Among
PPD-type ginsenosides, ginsenoside Rd was at the highest level after
5 d of fermentation. Rd is the major ginsenoside in the ﬁnal
fermentation product [13], and it can be converted from Rb1, Rb2,
and Rc by the removal of sugar (Fig. 1). We, therefore, suggest that
the relatively higher level of Rd was due to the conversion of Rb1,
Rb2, and Rc during fermentation. The time courses of ginsenosides
concentrations during fermentation are shown in Fig. 5. These re-
sults conﬁrmed that Rb1, Rb2, and Rc decreased continuously during
the 5 d of fermentation. By contrast, Rd was maintained or slightly
increased after 1 d of fermentation. In particular, a dramatic increase
in Rd was observed in the GMC inoculated with L. delbrueckii subsp.
bulgaricus, which had relatively low b-glucosidase activity during
fermentation. Many studies have been conducted on the biotrans-
formation of the ginsenoside Rb1 into Rd during fermentation
[1,10,24]. However, Rd can be continuously converted into CK by cell
extracts from various food-grade edible microorganisms including
L. mesenteroides [25] and Lactobacillus paralimentarius [26]. We
conﬁrmed that Rd decreased during the ﬁrst 2 d of fermentation,
suggesting that it can be converted more quickly into smaller
deglycosylated forms such as Rg3, Rh2, F2, and CK [27,28]. Ye et al [1]
reported that Rd yields from Rb1 were low due to the inhibition of
Rd production by other ginsenosides, low substrate tolerance,
requirement for pure substrates, and further transformation of Rd
into other compounds. In this paper, we used the same concentra-
tion of ginsenosides standard (1 ppm) as a culture to investigate the
reaction rates related to the conversion of ginsenosides into their
smaller deglycosylated forms. In our model culture, it appeared that
the conversion rate of Rd into its smaller deglycosylated form was
more rapid than that of Rd from Rb1, Rb2 and Rc.
Among PPT-type ginsenosides, a low level of Re was observed
in the GMCs after fermentation (Table 1). The decrease in ReTable 1
The residual ginsenoside contents of ginsenosides model cultures after 5 days of fermen
Ginsenosides
(ppm)
M
Lactobacillus
fermentum
Lactobacillus
delbrueckii
subsp. lactis
Biﬁdobacterium
longum
PPD Rb1 0.772  0.025Bcd1) 0.624  0.010Aab 0.579  0.089Aa
Rb2 0.682  0.064BCbc 0.569  0.014ABa 0.607  0.007ABCa
Rc 0.676  0.072bc 0.597  0.012a 0.630  0.007a
Rd 0.589  0.103Ab 0.741  0.091ABabc 0.820  0.114BCab
PPT Re 0.728  0.029ABbc 0.723  0.150ABabc 0.632  0.067Aa
Rg1 0.912  0.070ABd 0.863  0.003Abc 0.905  0.008ABb
Rg2 0.905  0.065Ad 0.905  0.007Ac 0.971  0.007ABb
Rf 0.423  0.008Aa 1.150  0.214Bd 0.783  0.239ABab
Total 5.691  0.029 6.176  0.464 5.932  0.573
Values with different small letters in a column and capital letters in a row are signiﬁcan
PPD, protopanaxadiol; PPT, protopanaxatriol
1) Mean  SD (n ¼ 3)concentration during fermentation is in agreement with other
studies, but to varying degrees according to the LAB strain. The
evolution of Rg1 and Rg2 contents in the GMC inoculated with LAB
was very different from the other ginsenosides (Fig. 5). Unlike other
ginsenosides, Rg1 and Rg2 reached their lowest levels after 1e2 d of
fermentation and then increased gradually. In all cases, Rg1 and Rg2
levels in GMCs fermented with LAB were signiﬁcantly higher than in
other samples after fermentation, indicating that Rg1 and Rg2 were
intermediate products of Re and that the bioconversion rate of Re
into deglycosylated forms such as F1 and Rh1 was slower than those
of other ginsenosides. Many studies have reported a decrease in Re
and an increase in Rg2 during fermentation. However, the opposite
was reported for Rg1 change during fermentation. Hsu et al [13]
showed that after 30 d of fermentation with Ganoderma lucidum,
ginsenoside Rg1 increased signiﬁcantly, whereas ginsenoside Re
decreased during fermentation. Wang et al [16] reported that Re and
Rg1were decreased slightly, whereas Rg2 and Rh1were increased in
red ginseng extract fermented by human intestinal microﬂora. The
contrast in Rg1 changes during fermentation seems to be due to
differences in bioconversion conditions such as microorganism and
microbial enzymes. To avoid variability in the preparations, this
research used commercially available ginsenoside mix as a model
culture, and the time courses of ginsenoside concentrations during
fermentation with LAB were studied. In our model system, the
conversion rate of Rg1 and Rg2 during fermentation may have been
similar because we added the same concentration of ginsenosides
standard (1 ppm) before fermentation. Moreover, we conﬁrmed that
the conversion rate of Rg1 and Rg2 into smaller deglycosylated forms
such as F1 and Rh1 was faster than the conversion rate from Re
during the ﬁrst 2 d of fermentation by LAB.
Although ginsenoside Rf is known to have higher chemical
stability than other ginsenosides, it was reported that Rf trans-
formed into ginsenoside Rg9 through a dehydration reaction under
thermal and acidic conditions [29]. However, this transformation is
not due to the removal of sugar from Rf leading to transformation
into a smaller deglycosylated form. Rf does not have the readily
hydrolytic sugar bonded to the hydroxyl at 21-C in its dammarane
skeleton [30]. In this study, it may be that Rf was converted into
other forms by LAB, but high variability was found among the
samples.
The time courses of ginsenoside concentrations during
fermentation with LAB were studied and commercially available
ginsenoside mix was used as a model culture for the clear identi-
ﬁcation of the metabolic changes in ginsenosides. Among PPD-type
ginsenosides, although ginsenosides Rb1, Rb2, and Rc decreasedtation with six lactic acid bacteria strains
icroorganisms
Leuconostoc
mesenteroides
Lactobacillus
plantarum
L. delbrueckii
subsp.
bulgaricus
Average
0.797  0.005Bab 0.597  0.041Abc 0.736  0.017Ba 0.685
0.708  0.069BCa 0.506  0.012Aab 0.719  0.099Ca 0.632
0.683  0.065a 0.569  0.061bc 0.703  0.069a 0.643
0.817  0.075BCabc 0.672  0.053Ac 1.022  0.069Cb 0.777
0.884  0.112Bbc 0.661  0.053Ac 0.804  0.017ABab 0.739
0.959  0.002Bc 0.841  0.027Ad 0.954  0.021Bab 0.906
0.947  0.013ABc 0.917  0.026Ad 0.999  0.003Bb 0.941
0.724  0.018ABa 0.386  0.097Aa 0.693  0.260ABa 0.693
6.522  0.091 5.152  0.103 6.634  0.075
tly different at p < 0.05
Lactobacillus fermentum 
L. delbrueckii subsp. lactis
Bifidobacterium longum
Leuconostoc mesenteroides 
subsp. mesenteroides
Lactobacillus plantarum
Lactobacillus delbrueckii 
subsp. bulgaricus
Fig. 5. The time courses of ginsenosides concentrations during fermentation with six lactic acid bacteria strains. Ginseng ginsenosides mix, including Rb1, Rb2, Rc, Rd, Re, Rf, Rg1,
and Rg2 (1 ppm of each component in distilled water), was used as a model culture to facilitate clear identiﬁcation of the metabolic changes. Values are expressed as the
mean  SD (n ¼ 3).
S.-E. Park et al / Biotransformation of ginsenosides by LAB 41continuously, Rd was maintained or increased slightly after 1 d of
fermentation, suggesting that the conversion rate of Rd into smaller
deglycosylated formswasmore rapid than that of Rd fromRb1, Rb2,
and Rc. Among PPT-type ginsenosides, Re decreased continuously,
whereas ginsenosides Rg1 and Rg2 increased after 1e2 d of
fermentation, indicating that these ginsenosides were the inter-
mediate products of Re, and that the bioconversion of Re into
smaller deglycosylated forms was faster than the conversion rate
from Re during the ﬁrst 2 d of fermentation by LAB.
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